Agios Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Agios Pharmaceuticals has a total shareholder equity of $811.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $937.1M and $126.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$776.93m |
Equity | US$811.02m |
Total liabilities | US$126.10m |
Total assets | US$937.12m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8AP's short term assets ($833.8M) exceed its short term liabilities ($68.0M).
Long Term Liabilities: 8AP's short term assets ($833.8M) exceed its long term liabilities ($58.1M).
Debt to Equity History and Analysis
Debt Level: 8AP is debt free.
Reducing Debt: 8AP had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 8AP has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 8AP has sufficient cash runway for 2.8 years if free cash flow continues to reduce at historical rates of 0.4% each year.